Search terms
Results 1 - 1 of 1 - ordered by :

Abstract Aims X-VeRT is the first prospective randomized trial of a novel oral anticoagulant in patients with atrial fibrillation undergoing elective cardioversion. Methods and results We assigned ...

European Heart Journal, ESC Hot Line Barcelona, Riccardo Cappato, Michael D. Ezekowitz, Allan L. Klein, A. John Camm, Chang-Sheng Ma, Jean-Yves Le Heuzey, Mario Talajic, Maurício Scanavacca, Panos ...

Date : 14/12/2014